SMTL ID : 8d0d.1

Human SARM1 TIR domain bound to an NB-7-ADPR adduct

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.96 Å

Oligo State

homo-dimer

Ligands

2 x Q0L: [[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2~{R},3~{S},4~{R})-5-[4-[3-[3-(4-chlorophenyl)propanoylamino]-4-methyl-1~{H}-pyrazol-5-yl]pyridin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methyl hydrogen phosphate(Non-covalent)

Q0L.1: 12 residues within 4Å: Chain A: S.10, Y.11, R.12, R.13, D.37, L.41, F.46, L.50, W.81, V.82, E.85 Chain B: E.129 18 PLIP interactions: 17 interactions with chain A, 1 interactions with chain B Hydrophobic interactions: A:L.41, A:F.46, A:L.50 Hydrogen bonds: A:S.10, A:Y.11, A:R.13, A:R.13, B:E.129 Water bridges: A:R.12, A:R.12, A:K.71, A:K.71, A:D.80, A:D.80, A:W.81 Salt bridges: A:R.12, A:K.71 pi-Stacking: A:F.46 Q0L.2: 11 residues within 4Å: Chain B: S.10, Y.11, R.12, R.13, D.37, L.41, F.46, L.50, W.81, V.82, E.85 14 PLIP interactions: 12 interactions with chain B, 2 interactions with chain A Hydrophobic interactions: B:L.41, B:F.46, B:L.50 Hydrogen bonds: B:S.10, B:Y.11, B:R.13 Water bridges: B:R.12, B:R.12, B:N.14, B:K.71, A:E.129, A:E.129 Salt bridges: B:R.12 pi-Stacking: B:F.46

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bratkowski, M. et al., Uncompetitive, adduct-forming SARM1 inhibitors are neuroprotective in preclinical models of nerve injury and disease. Neuron (2022)

Release Date

2022-09-21

Peptides

NAD(+) hydrolase SARM1: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

NAD(+) hydrolase SARM1

Related Entries With Identical Sequence